Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease
Authors:
- 22 May 2018
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 14 (8) , 981-988
Abstract
Introduction: Lifetime risks are the probabilities of progressing to Alzheimer's disease (AD) dementia during one's lifespan. Here, we report the first estimates of the lifetime and ten‐year risks of AD dementia based on age, gender, and biomarker tests for preclinical disease.Methods: We used a multistate model for the disease process together with US death rates.Results: Lifetime risks of AD dementia vary considerably by age, gender, and the preclinical or clinical disease state of the individual. For example, the lifetime risks for a female with only amyloidosis are 8.4% for a 90‐year old and 29.3% for a 65‐year old. Persons younger than 85 years with mild cognitive impairment, amyloidosis, and neurodegeneration have lifetime risks of AD dementia greater than 50%.Discussion: Most persons with preclinical AD will not develop AD dementia during their lifetimes. Lifetime risks help interpret the clinical significance of biomarker screening tests for AD.Keywords
Funding Information
- National Institutes of Health (R21AG055361)
This publication has 45 references indexed in Scilit:
- Personalized estimates of breast cancer risk in clinical practice and public healthStatistics in Medicine, 2011
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseAnnals of Neurology, 2011
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Biracial Population Study of Mortality in Mild Cognitive Impairment and Alzheimer DiseaseArchives of Neurology, 2009
- The Lifetime Risk of StrokeStroke, 2006
- The Aging, Demographics, and Memory Study: Study Design and MethodsNeuroepidemiology, 2005
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- The incidence of dementia in CanadaNeurology, 2000
- Lifetime risk of dementia and Alzheimer's diseaseNeurology, 1997